Publications by authors named "MacLean Hall"

Claim this Profile
C
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
Lilit Karapetyan, Joel Kuriakose, Matthew C Perez, Johannes R Ali, MacLean S Hall

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients.
Lilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, Kimberly Ward, Jamie Chau, MacLean S Hall

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and Apoptosis.
Sowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska, Maria Biernacki, Robbert J C Slebos, MacLean S Hall

Mol Cancer Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes.
Nina Obertopp, Rebecca A Bekker, G Daniel Grass, Tomas Zelenka, Ashley Thomas, Amy M Hall, MacLean S Hall

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial.
Robin Park, Fahad Rind, Tyler Kristoff, Jiannong Li, Michael Schell, MacLean S Hall

Am J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Robin Park, Jiannong Li, Robbert J C Slebos, Ritu Chaudhary, Maria I Poole, MacLean S Hall

Oral Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease.
Mariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, Hasan Alhaddad, Zhihua Chen, MacLean Hall

bioRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigen-specific CD4 tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, Holly Branthoover, Sebastian Snedal, Amy M Hall

J Immunother Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.
MacLean S Hall, John E Mullinax, Cheryl A Cox, Amy M Hall, Matthew S Beatty

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function.
John E Mullinax, MacLean Hall, Matthew Beatty, Amy M Weber, Zachary Sannasardo

J Immunother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients.
Ahmet Murat Aydin, MacLean Hall, Brittany L Bunch, Holly Branthoover, Zachary Sannasardo

Int Immunopharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells.
Patrick Innamarato, Sarah Asby, Jennifer Morse, Amy Mackay, MacLean Hall

J Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy.
Patrick Innamarato, Krithika Kodumudi, Sarah Asby, Benjamin Schachner, MacLean Hall

Mol Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer.
Michael Poch, MacLean Hall, Autumn Joerger, Krithika Kodumudi, Matthew Beatty

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.
John E Mullinax, MacLean Hall, Sangeetha Prabhakaran, Jeffrey Weber, Nikhil Khushalani

Front Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors.
MacLean Hall, Hao Liu, Mokenge Malafa, Barbara Centeno, Pamela J Hodul

J Immunother Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers on melanoma patient T cells associated with ipilimumab treatment.
Wenshi Wang, Daohai Yu, Amod A Sarnaik, Bin Yu, Maclean Hall

J Transl Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma.
Amod A Sarnaik, Bin Yu, Daohai Yu, Dawn Morelli, Maclean Hall

Clin Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis